Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Regulatory Peptides

• Publication date

  2004-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.REGPEP.2003.12.012PMID 15003833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands

  2003cited by this paper
• Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.

  2003cited by this paper
• The CRF peptide family and their receptors: yet more partners discovered.

  2002cited by this paper
• Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.

  2002cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.

  2001cited by this paper
• Characterization of Three Corticotropin-Releasing Factor Receptors in Catfish: A Novel Third Receptor Is Predominantly Expressed in Pituitary and Urophysis*† * The nucleotide sequences reported in this paper have been submitted to the GenBank database with accession numbers cfCRF-R1, AF229359; cfCRF

  2001cited by this paper
• A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists

  2001cited by this paper
• Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.

  2001cited by this paper
• Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor*

  2001cited by this paper
• Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

  2001cited by this paper
• Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

  2001cited by this paper
• Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis.

  2001cited by this paper
• Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

  2001cited by this paper
• Molecular biology of the CRH receptors-- in the mood.

  2001cited by this paper
• The role of CRF receptor subtypes in stress-induced behavioural responses.

  2000cited by this paper
• Regulation of the Stress Response by Corticotropin-Releasing Factor Receptors

  2000cited by this paper
• Neuroendocrinology in Physiology and Medicine

  2000cited by this paper
• Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.

  2000cited by this paper
• Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras.

  2000cited by this paper
• A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3

  2000cited by this paper
• The role of corticotropin-releasing factor in depression and anxiety disorders.

  1999cited by this paper
• 7TM receptors: the splicing on the cake.

  1999cited by this paper
• The ligand‐selective Domains of Corticotropin‐Releasing Factor Type 1 and Type 2 Receptor Reside in Different Extracellular Domains

  1999cited by this paper
• Human CRF2 α and β splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

  1999cited by this paper
• Isolation and Pharmacological Characterization of Two Functional Splice Variants of Corticotropin‐Releasing Factor Type 2 Receptor from Tupaia belangeri

  1999cited by this paper
• Identification of Amino Acids in the N‐Terminal Domain of Corticotropin‐Releasing Factor Receptor 1 that Are Important Determinants of High‐Affinity Ligand Binding

  1999cited by this paper
• Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.

  1999cited by this paper
• Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

  1999cited by this paper
• Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

  1998cited by this paper
• Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution.

  1998cited by this paper
• The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.

  1998cited by this paper
• Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

  1998cited by this paper
• Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.

  1997cited by this paper
• Identification of Two Corticotropin‐Releasing Factor Receptors from Xenopus laevis with High Ligand Selectivity: Unusual Pharmacology of the Type 1 Receptor

  1997cited by this paper
• Regulation of Corticotropin‐Releasing Factor Receptor Function in Human Y‐79 Retinoblastoma Cells: Rapid and Reversible Homologous Desensitization but Prolonged Recovery

  1997cited by this paper
• Cloning and characterization of human urocortin.

  1996cited by this paper
• Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896]

  1996cited by this paper
• Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

  1995cited by this paper
• Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.

  1995cited by this paper
• Expression cloning of a human corticotropin-releasing-factor receptor.

  1993cited by this paper
• Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

  1993cited by this paper
• Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei.

  1981cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper

• Corticotropin-releasing factor receptors in GtoPdb v.2025.3

  2025cites this paper
• Corticotropin-releasing factor receptors in GtoPdb v.2023.1

  2023influential citation
• Corticotropin-releasing factor receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019influential citation
• Immunomodulatory role of urotensins in teleost Channa punctatus.

  2011cites this paper
• Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death

  2010cites this paper
• Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists

  2007cites this paper
• Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptor.

  2006cites this paper
• Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

  2006cites this paper
• Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometrium explants estimated from a mathematical model of uterine contraction.

  2005cites this paper
• Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.

  2005cites this paper
• NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.

  2004cites this paper